Last reviewed · How we verify
NCT04139629
Cohort Study Investigating the Association Between Antichlamydial Antibody Positivity and ART Outcomes in Women With TFI
NA trial testing antichlamydial antibody test in Antichlamydial Antibodies in 292 participants. Status unknown.
30 January 2020
Quick facts
| Lead sponsor | D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 292 |
| Start date | 25 October 2019 |
| Primary completion | 30 January 2020 |
| Estimated completion | 30 October 2021 |
| Sites | 1 location across Russia |
Drugs / interventions tested
- antichlamydial antibody test
- treatment of infertility with ART — full drug profile →
Conditions studied
- Antichlamydial Antibodies — all drugs for Antichlamydial Antibodies →
- Chlamydia Trachomatis Infection — all drugs for Chlamydia Trachomatis Infection →
- Infertility — all drugs for Infertility →
- Tubal Factor Infertility — all drugs for Tubal Factor Infertility →
Sponsor
D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology
Who can join
Adults 20 to 41, female only, with Antichlamydial Antibodies or Chlamydia Trachomatis Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In a prospective cohort study investigators will examine characteristics and clinical outcomes of treatment with ART in women with tubal factor infertility (TFI) with regard to seropositivity to antichlamydial antibodies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04139629
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology trials
Trials by the same sponsor.
- NCT04458454 — "Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles" · completed
- NCT03166189 — Autologous Bone Marrow-derived Mesenchymal Stem Cells for Atrophic Endometrium in Patients With Repeated IVF Failures · Phase 2 · completed
- NCT03177538 — Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04139629 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology
- Last refreshed: 24 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04139629.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing